Charles Cherington, Director, 10% Owner at Eterna Therapeutics Inc. (ERNA), bought 523,512 shares at $3.28 ($1.7M) on 2022-12-02, disclosed to the SEC on 2022-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 261,756 | $859K | 50.0% |
| 2 | $3.28 | 261,756 | $859K | 50.0% |
| Total | $3.28 avg | 523,512 | $1.7M | 100% |
| Filing → |
| ERNA | BUY | 2025-04-04 | $754K | — | Filing → |
| CMRA | BUY | 2023-09-11 | $2.1M | — | Filing → |
| CMRA | BUY | 2023-08-25 | $898K | — | Filing → |